Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Dr Lennard Lee

Dr Lennard Lee, Academic Clinical Lecturer at the Department of Oncology, University of Oxford, has been awarded the 2020 Association of Cancer Physicians (ACP) McElwain Prize for his contribution to the development of Medical Oncology in the UK.

During the COVID-19 pandemic, Dr Lee’s contributions were best reflected in his creation and implementation of a national prospective observational cohort study of cancer patients during the COVID-19 pandemic, the UK Coronavirus Cancer Monitoring Project (UK CCMP). This was one of the largest global registries and the first to identify that cancer treatments can be safely delivered during a COVID-19 pandemic.

The initial phase of the project has been successfully achieved with the roll out and implementation of the UK CCMP emergency observational response network, as well as studies to determine those in our population who are most at risk – such as blood cancer patients.

Thanks to this project, the UK oncology community now has the tools and the mechanism to learn from each case of COVID-19 in cancer patients and the evidence required to bring about clinical management/service/treatment decision changes to improve the outcomes of cancer patients. The data from this project has helped form the guidelines which have been published from NHS England about the resumption of cancer services and led to the return of near-normal chemotherapy prescribing levels.

Building on the success of this work, Lennard is now leading on further studies to understand and better safeguard cancer patients during the pandemic. He has co-launched projects on COVID-19 vaccine efficacy, understanding how this is impacted by cancer treatments, and studies to identify other effective COVID-19 risk reduction interventions.

Lennard Lee said “I am honoured to receive this award on behalf of all the clinicians and researchers who took part in the UKCCMP. The work by the UK oncology community had global impact, demonstrating that cancer patients can be treated safely during the pandemic. No one should be denied appropriate cancer treatments and it is important that we continue to deliver research excellence in order to protect the vulnerable during this pandemic”.

For more information about the UK CCMP, visit their website.

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.